Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology
Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology
VANCOUVER, BC / ACCESSWIRE / April 17, 2024 / Blackhawk Growth Corp. (CSE:BLR)(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to provide an update on Hardenbrook portfolio company - Asthmatic AI.
不列顛哥倫比亞省溫哥華/ACCESSWIRE/2024年4月17日/Blackhawk Growth Corp.（CSE: BLR）（法蘭克福:0JJ）（“公司” 或 “黑鷹”）很高興提供哈登布魯克投資組合公司Asthmatic AI的最新情況。
We are pleased to report that Asthmatic AI, a Hardenbrook and Life AI Corp asset ( has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma.
我們很高興地向大家報告，Asthmatic AI（哈登布魯克和Life AI Corp的資產）已經完成了50名人體臨床試驗的參與者，目前正在研究接下來的250名參與者，開發用於哮喘臨床管理的哮喘發作預測技術。
Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition.
獨特的是，Asthmatic AI通過智能手機使用可穿戴設備和移動應用程序來收集數據，評估哮喘發作的風險，然後在哮喘發作之前進行干預。人工智能模型將個人的生物物理信息（例如心率、呼吸頻率、心率變異性、血壓、咳嗽和喘息率）與公共衛生數據、花粉和位置數據進行交叉引用，以解釋個人的哮喘發作風險。根據世界衛生組織的數據，每天報告超過1000例哮喘死亡病例，以及社會、就業、教育和家庭的負擔，Asthmatic AI爲管理這種嚴重的健康狀況提出了一種新的解決方案。
Hardenbrook Group works with world class research-intensive organisations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally.
哈登布魯克集團與世界一流的研究密集型組織合作，尋找有價值的知識產權進行投資和商業化。這使Blackhawk能夠孵化併購或將這些新的創新公司分拆爲全球證券交易所的新上市。
Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.
哈登布魯克已將其專注於健康科技人工智能的公司投資組合，包括哮喘人工智能、情緒人工智能和自閉症人工智能，與健康科技人工智能相關的大量項目合併，這些項目將在近期推出。Life AI Corp將成爲所有健康科技人工智能公司的控股公司，同時也準備分拆並上市上市。
Blackhawk CEO Justin Hanka (left) and Chairman Anoosh Manzoori (right). The Board's focus is on scalable technology opportunities particularly in AI, health and enviro-tech.
黑鷹首席執行官賈斯汀·漢卡（左）和董事長阿努什·曼佐裏（右）。董事會的重點是可擴展的技術機會，尤其是在人工智能、健康和環境技術領域。
About Blackhawk Growth
關於《黑鷹成長》
Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies.
Blackhawk是一家投資控股公司，希望通過收購和發展高增長公司爲其股東創造可觀的價值。
To receive our latest updates, please register here:
要接收我們的最新更新，請在此處註冊：
For more information on Hardenbrook:
有關哈登布魯克的更多信息：
For more information about Life AI Corp:
有關 Life AI Corp 的更多信息：
Contact
聯繫我們
Justin Hanka. Chief Executive Officer
justin@hardenbrook.group
61433140886
賈斯汀·漢卡。首席執行官
justin@hardenbrook.group
61433140886
Cautionary Note Regarding Forward-Looking Statement
關於前瞻性陳述的警示性說明
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at . Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
本新聞稿中的所有陳述，除歷史事實陳述外，均爲適用證券法所指的有關公司的 “前瞻性信息”。公司提供前瞻性陳述的目的是傳達有關當前預期和未來計劃的信息，並提醒讀者，此類陳述可能不適用於其他目的。就其性質而言，這些信息存在固有的風險和不確定性，這些風險和不確定性可能是一般性的，也可能是具體的，有可能導致預期、預測、預測、預測或結論不準確，假設可能不正確，目標、戰略目標和優先事項無法實現。這些風險和不確定性包括但不限於公司根據公司SEDAR簡介在公開文件中確定和報告的風險和不確定性，網址爲。儘管公司試圖確定可能導致實際行動、事件或結果與前瞻性信息中描述的重大差異的重要因素，但可能還有其他因素導致行動、事件或結果與預期、估計或預期不符。無法保證此類信息會被證明是準確的，因爲實際結果和未來事件可能與此類聲明中的預期存在重大差異。除非法律要求，否則公司不打算或義務更新或修改任何前瞻性信息，無論是由於新信息、未來事件還是其他原因。
SOURCE: Blackhawk Growth Corp.
資料來源：黑鷹增長公司
譯文內容由第三人軟體翻譯。